Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 39.10
-0.15 (-0.38%)
Sep 5, 2025, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 8.10 billion as of September 5, 2025. Its market cap has decreased by -22.35% in one year.
Market Cap
8.10B
Enterprise Value
8.86B
Revenue
727.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.10
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 8.10B, an increase of 1,286.42%. That is a compound annual growth rate of 16.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 8.10B | -9.69% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | 4.13B | 38.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 378.45B |
| PharmaEssentia | 171.63B |
| Bora Pharmaceuticals Co., LTD. | 91.46B |
| Lotus Pharmaceutical | 51.15B |
| Lumosa Therapeutics | 40.18B |
| Oneness Biotech | 35.77B |
| Polaris Group | 29.31B |
| Center Laboratories | 28.67B |